Skip to main content

Nonprofit · EIN 13-3916689

GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC

Also known as CURE CANCER NOW

Tax-exempt · NEW YORK, NY 10014

Financials

$3.6M$3.6M2023$2.2M$2.4M2024
Revenue Expenses · by fiscal year end
Financials of GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$2,201,642$2,444,810-$243,168$5,954,580$4,219,091$1,735,489
December 31, 2023990$3,625,026$3,622,772$2,254$6,114,423$4,403,588$1,710,835
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$1,981,825
Program service revenue
$0
Investment income
$208,446
Net gain from sales of assets
-$31,863
Other revenue
$11,371

Expenses

Grants and similar amounts paid
$1,520,750
Other salaries and wages
$389,594
Salaries, compensation and benefits (total)
$507,185
Professional fundraising fees
$0
Legal fees
$3,325
Accounting fees
$28,604
Occupancy
$18,001
Travel
$3,467
Program services (functional)
$2,128,229
Management and general (functional)
$159,163
Fundraising (functional)
$157,418

Balance sheet and other

Total assets, start of year
$6,114,423
Total assets, end of year
$5,954,580
Total liabilities, end of year
$4,219,091
Net assets, end of year
$1,735,489
Publicly traded securities
$3,493,607
Net assets without donor restrictions
$1,211,750
Net assets with donor restrictions
$523,739
Gross receipts
$3,671,018
Employees
0
Volunteers
9
Year formed
1996
State of legal domicile
DE

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
DENISE RICHPRESIDENT & CO-FOUNDER
Trustee or director, Officer
3$0
MICHELE RELLATREASURER
Trustee or director, Officer
3$0
DANIELLA RICH KILSTOCKDIRECTOR
Trustee or director
3$0
ILONA RICH SCHACHTERDIRECTOR
Trustee or director
3$0
STEPHEN D NIMER MDDIRECTOR
Trustee or director
3$0
STAR JONESDIRECTOR
Trustee or director
3$0
PATRICIA QUICKDIRECTOR
Trustee or director
3$0
PAUL SCHINDLER ESQDIRECTOR
Trustee or director
3$0
LORRAINE ESCHWARTZDIRECTOR
Trustee or director
3$0
990 for the year ended December 31, 2023: 13 people
NameTitleHours / weekCompensation
JENNIFER RANIERIEXECUTIVE DIRECTOR
Officer
40$197,776
MICHELE KEENEDIRECTOR OF DEVELOPMENT
Highest-paid employee
40$179,158
DENISE RICHPRESIDENT & CO-FOUNDER
Trustee or director, Officer
3$0
BROOKE MILLSTEINVICE CHAIR
Trustee or director, Officer
3$0
STAR JONESDIRECTOR
Trustee or director
3$0
PATRICIA QUICKDIRECTOR
Trustee or director
3$0
MICHELE RELLADIRECTOR
Trustee or director
3$0
ILONA RICH SCHACHTERDIRECTOR
Trustee or director
1$0
THOMAS C QUICKDIRECTOR
Trustee or director
3$0
DANIELLA RICH KILSTOCKDIRECTOR
Trustee or director
3$0
PAUL SCHINDLERDIRECTOR
Trustee or director
3$0
LORRAINE E SCHWARTZDIRECTOR
Trustee or director
3$0
STEPHEN D NIMER MDDIRECTOR
Trustee or director
3$0

Address and contacts

Address (IRS master file)
430 W 14TH STREET, NEW YORK, NY 10014-1011
Principal officer (990 for 2024)
DENISE RICH, 430 W 14TH STREET, NEW YORK, NY 10014
Signed the 990
DENISE RICH, PRESIDENT
Phone
(646) 861-2033
Return prepared by
CONDON O'MEARA MCGINTY & DONNELLY LLP

Mission

THE PURPOSE OF GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH, INC. (THE "FOUNDATION") IS TO ENCOURAGE THE DEVELOPMENT OF MORE EFFECTIVE THERAPIES FOR PATIENTS WITH LEUKEMIA, LYMPHOMA AND RELATED CANCERS. THE FOUNDATION FUNDS INNOVATIVE CLINICAL OR BASIC SCIENCE RESEARCH THAT WILL LEAD TO NOVEL THERAPEUTIC APPROACHES THAT COULD REPLACE, OR BE USED IN COMBINATION WITH, EXISTING EFFECTIVE THERAPIES. SUCH THERAPEUTIC APPROACHES COULD INCLUDE INTEGRATIVE (INTEGRATIVE / COMPLEMENTARY) MEDICINE. THE FOUNDATION FUNDS RESEARCH TO IMPROVE THE EFFICENCY OF CANCER TREATMENTS, REDUCE THEIR TOXICITY AND IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH LEUKEMIA OR LYMPHOMA. THE FOUNDATION ALSO SUPPORTS LIMITED SCIENTIFIC INTERCHANGE BETWEEN SELECT LEADERS IN DIFFERENT AREAS OF BIO AND INTEGRATIVE MEDICAL RESEARCH TO DEVELOP UNIQUE AND IMPORTANT COLLABORATIVE EFFORTS THAT WILL LEAD TO IMPROVEMENTS IN THE TREATMENT AND CARE OF PATIENTS WITH LEUKEMIA AND LYMPHOMA.

990 for the year ended December 31, 2024

Program accomplishments

  • FOUNDATION FUNDS INNOVATIVE CLINICAL OR BASIC SCIENCE RESEARCH THAT WILL LEAD TO NOVEL THERAPEUTIC APPROACHES THAT COULD REPLACE, OR BE USED IN COMBINATION WITH EXISTING EFFECTIVE THERAPIES FOR PATIENTS WITH LEUKEMIA, LYMPHOMA AND RELATED CANCERS.
    Expenses $2,128,229 · grants $1,520,750

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
13-3916689
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1996
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$5,954,580
Income (IRS master file)
$3,671,018

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$2,201,642$2,444,810$5,954,580XML
990December 2023$3,625,026$3,622,772$6,114,423XML
990December 2022$2,464,150$1,897,102$5,133,948IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 13-3916689).

Questions about GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC

What is the EIN of GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC?
The employer identification number (EIN) of GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC is 13-3916689.
Is GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1996.
Are donations to GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC?
The 990 for the year ended December 31, 2024 names DENISE RICH.
Who are the officers and directors of GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC?
The 990 for the year ended December 31, 2024 lists 9 people; 0 received compensation from the organization.
How much revenue does GABRIELLES ANGEL FOUNDATION FOR CANCER RESEARCH INC have?
On its 990 for the year ended December 31, 2024 it reported revenue of $2,201,642, expenses of $2,444,810 and total assets of $5,954,580 at year end.

Other nonprofits in NEW YORK

All nonprofits in NEW YORK · New York · Philanthropy, voluntarism and grantmaking foundations